Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 222 participants.
Also called NCT02640794
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 222 participants
- Registry
-
NCT02640794
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada, Chile, Spain
- Registry status
- Completed
Technical summary
Registry record NCT02640794. Randomized; no masking; primary purpose prevention. Start 2015-01 (actual); primary completion 2017-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
- Acronym
- ARTE
- Condition
- Aortic Valve Disease
- Condition
- Myocardial Infarction
- Condition
- Stroke
- Condition
- Bleeding
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Record details
- Record id
cardio:ct-nct02640794- Content hash
0b666d1c629e84493c80175d497f6f723b74111b35162ae28381c3dc1e422883